搜尋





搜尋





市場行情
/
股票
/
nrix
/

Nurix Therapeutics Inc

NRIX

添加自選

23.210USD

-0.370-1.57%

收盤 07-31 16:00（美東）報價延遲15分鐘

2.41B總市值

虧損本益比TTM

Nurix Therapeutics Inc

23.210

-0.370-1.57%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

NRIX 利潤表

您可以在這裡找到Nurix Therapeutics Inc的年度或季度收入報告，以深入了解Nurix Therapeutics Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

營業總收入

-79.47%9.04M

-66.12%6.25M

2.21%13.58M

-37.29%7.89M

264.34%44.06M

11.26%18.45M

-12.37%13.28M

-31.84%12.59M

-60.58%12.09M

30.74%16.59M

123.49%15.16M

71.13%18.47M

168.33%30.68M

31.85%12.69M

-8.29%6.78M

5.26%10.79M

61.22%11.43M

92.00%9.62M

10.57%7.40M

150.97%10.25M

69.56%7.09M

74.97%5.01M

259.24%6.69M

-61.39%4.08M

-55.69%4.18M

-68.98%2.86M

--1.86M

--10.58M

--9.44M

--9.23M

營業收入

-79.47%9.04M

-66.12%6.25M

2.21%13.58M

-37.29%7.89M

264.34%44.06M

11.26%18.45M

-12.37%13.28M

-31.84%12.59M

-60.58%12.09M

30.74%16.59M

123.49%15.16M

71.13%18.47M

168.33%30.68M

31.85%12.69M

-8.29%6.78M

5.26%10.79M

61.22%11.43M

92.00%9.62M

10.57%7.40M

150.97%10.25M

69.56%7.09M

74.97%5.01M

259.24%6.69M

-61.39%4.08M

-55.69%4.18M

-68.98%2.86M

--1.86M

--10.58M

--9.44M

--9.23M

營業費用

11.77%103.25M

21.43%98.75M

24.03%96.67M

47.74%99.28M

52.36%92.38M

31.57%81.32M

28.84%77.94M

14.91%67.20M

5.56%60.63M

11.08%61.80M

9.05%60.49M

1.69%58.48M

0.51%57.44M

6.25%55.64M

22.32%55.47M

46.52%57.51M

70.56%57.15M

77.31%52.37M

69.87%45.35M

68.62%39.25M

92.42%33.51M

91.56%29.53M

73.06%26.70M

76.45%23.28M

37.87%17.41M

27.37%15.42M

--15.43M

--13.19M

--12.63M

--12.10M

研發費用

12.24%87.65M

20.78%84.14M

23.50%83.02M

55.22%86.12M

59.63%78.10M

39.31%69.66M

35.22%67.22M

15.93%55.48M

6.90%48.92M

9.14%50.01M

7.82%49.71M

0.20%47.86M

-3.64%45.76M

6.21%45.82M

26.21%46.11M

54.54%47.76M

82.71%47.49M

87.53%43.14M

78.68%36.53M

63.19%30.91M

83.81%25.99M

77.40%23.00M

59.43%20.45M

72.05%18.94M

31.44%14.14M

24.28%12.97M

--12.82M

--11.01M

--10.76M

--10.43M

折舊攤銷及損耗

-55.76%2.25M

-46.80%2.20M

-50.73%2.12M

-51.09%2.03M

24.59%5.10M

6.17%4.13M

14.53%4.30M

22.52%4.15M

22.74%4.09M

22.26%3.89M

23.71%3.76M

17.26%3.38M

26.63%3.33M

41.15%3.18M

-24.99%3.04M

287.38%2.89M

308.06%2.63M

250.39%2.25M

528.73%4.05M

35.45%745.00K

30.30%645.00K

30.96%643.00K

17.30%644.00K

-1.08%550.00K

-17.91%495.00K

-23.99%491.00K

--549.00K

--556.00K

--603.00K

--646.00K

營業利潤

-94.95%-94.20M

-47.14%-92.50M

-28.52%-83.09M

-67.34%-91.39M

0.45%-48.32M

-39.02%-62.86M

-42.62%-64.66M

-36.49%-54.61M

-81.36%-48.54M

-5.28%-45.22M

6.89%-45.33M

14.35%-40.01M

41.45%-26.77M

-0.49%-42.95M

-28.29%-48.69M

-61.11%-46.72M

-73.07%-45.72M

-74.31%-42.74M

-89.69%-37.95M

-51.09%-29.00M

-99.65%-26.41M

-95.35%-24.52M

-47.51%-20.01M

-634.76%-19.19M

-314.73%-13.23M

-337.39%-12.55M

---13.56M

---2.61M

---3.19M

---2.87M

淨非營業利息收入（費用）

利息收入

-21.72%4.40M

-18.30%5.32M

-20.31%4.87M

-13.47%4.96M

37.56%5.62M

71.80%6.51M

81.05%6.12M

89.34%5.74M

64.15%4.08M

70.84%3.79M

71.21%3.38M

200.30%3.03M

692.36%2.49M

951.66%2.22M

568.81%1.97M

2487.18%1.01M

83.63%314.00K

-33.65%211.00K

118.52%295.00K

-94.22%39.00K

-23.32%171.00K

83.82%318.00K

-47.06%135.00K

246.15%675.00K

68.94%223.00K

-10.82%173.00K

--255.00K

--195.00K

--132.00K

--194.00K

稅前利潤

-110.30%-89.81M

-54.70%-87.17M

-33.62%-78.22M

-76.82%-86.42M

3.94%-42.70M

-36.02%-56.35M

-39.53%-58.54M

-32.16%-48.87M

-83.12%-44.46M

-1.71%-41.43M

10.19%-41.96M

19.09%-36.98M

46.53%-24.28M

4.23%-40.73M

-24.06%-46.72M

-57.85%-45.71M

-73.00%-45.40M

-75.73%-42.53M

-89.49%-37.66M

-56.39%-28.96M

-101.76%-26.24M

-95.51%-24.20M

-49.32%-19.87M

-666.12%-18.52M

-325.34%-13.01M

-362.63%-12.38M

---13.31M

---2.42M

---3.06M

---2.68M

所得稅

-135.66%-271.00K

--0.00

-100.00%0.00

744.44%760.00K

-100.00%0.00

--8.00K

--82.00K

--90.00K

----

-100.00%0.00

100.00%0.00

-100.00%0.00

7.32%44.00K

---123.00K

100.68%139.00K

545.45%71.00K

-80.48%41.00K

-100.00%0.00

-205970.00%-20.59M

22.22%11.00K

--210.00K

--10.00K

--9.00K

除稅後利潤

-106.00%-89.53M

-54.70%-87.17M

-33.60%-78.22M

-76.53%-86.42M

2.43%-43.46M

-35.73%-56.35M

-39.55%-58.55M

-32.38%-48.96M

-83.49%-44.55M

-1.93%-41.52M

10.19%-41.96M

19.09%-36.98M

46.53%-24.28M

4.23%-40.73M

-23.91%-46.72M

-58.52%-45.71M

-72.09%-45.40M

-75.21%-42.53M

-89.32%-37.70M

-55.72%-28.84M

-448.05%-26.38M

-95.91%-24.27M

-47.30%-19.91M

-662.96%-18.52M

347.07%7.58M

-361.49%-12.39M

---13.52M

---2.43M

---3.07M

---2.69M

持續經營利潤

-106.00%-89.53M

-54.70%-87.17M

-33.60%-78.22M

-76.53%-86.42M

2.43%-43.46M

-35.73%-56.35M

-39.55%-58.55M

-32.38%-48.96M

-83.49%-44.55M

-1.93%-41.52M

10.19%-41.96M

19.09%-36.98M

46.53%-24.28M

4.23%-40.73M

-23.91%-46.72M

-58.52%-45.71M

-72.09%-45.40M

-75.21%-42.53M

-89.32%-37.70M

-55.72%-28.84M

-448.05%-26.38M

-95.91%-24.27M

-47.30%-19.91M

-662.96%-18.52M

347.07%7.58M

-361.49%-12.39M

---13.52M

---2.43M

---3.07M

---2.69M

歸属于母公司的淨利潤

-106.00%-89.53M

-54.70%-87.17M

-33.60%-78.22M

-76.53%-86.42M

2.43%-43.46M

-35.73%-56.35M

-39.55%-58.55M

-32.38%-48.96M

-83.49%-44.55M

-1.93%-41.52M

10.19%-41.96M

19.09%-36.98M

46.53%-24.28M

4.23%-40.73M

-23.91%-46.72M

-58.52%-45.71M

-72.09%-45.40M

-75.21%-42.53M

-89.32%-37.70M

-55.72%-28.84M

-448.05%-26.38M

-95.91%-24.27M

-47.30%-19.91M

-662.96%-18.52M

347.07%7.58M

-361.49%-12.39M

---13.52M

---2.43M

---3.07M

---2.69M

歸屬普通股東的淨利潤

-106.00%-89.53M

-54.70%-87.17M

-33.60%-78.22M

-76.53%-86.42M

2.43%-43.46M

-35.73%-56.35M

-39.55%-58.55M

-32.38%-48.96M

-83.49%-44.55M

-1.93%-41.52M

10.19%-41.96M

19.09%-36.98M

46.53%-24.28M

4.23%-40.73M

-23.91%-46.72M

-58.52%-45.71M

-72.09%-45.40M

-75.21%-42.53M

-89.32%-37.70M

-55.72%-28.84M

-448.05%-26.38M

-95.91%-24.27M

-47.30%-19.91M

-662.96%-18.52M

347.07%7.58M

-361.49%-12.39M

---13.52M

---2.43M

---3.07M

---2.69M

基本每股收益

-55.56%-0.81

-17.44%-0.79

-10.09%-0.82

-52.66%-1.03

27.44%-0.52

10.82%-0.67

2.60%-0.75

1.07%-0.67

-59.61%-0.71

-0.30%-0.76

11.41%-0.77

24.33%-0.68

55.75%-0.45

20.78%-0.75

-2.37%-0.87

-38.28%-0.90

-67.90%-1.01

-52.02%-0.95

-65.17%-0.85

-10.13%-0.65

-190.41%-0.60

42.52%-0.63

56.87%-0.51

-176.62%-0.59

347.06%0.67

-361.50%-1.09

---1.19

---0.21

---0.27

---0.24

稀釋每股收益

-55.56%-0.81

-17.44%-0.79

-10.09%-0.82

-52.66%-1.03

27.44%-0.52

10.82%-0.67

2.60%-0.75

1.07%-0.67

-59.61%-0.71

-0.30%-0.76

11.41%-0.77

24.33%-0.68

55.75%-0.45

20.78%-0.75

-2.37%-0.87

-38.28%-0.90

-67.90%-1.01

-52.02%-0.95

-65.17%-0.85

-10.13%-0.65

-190.41%-0.60

42.52%-0.63

56.87%-0.51

-176.62%-0.59

347.06%0.67

-361.50%-1.09

---1.19

---0.21

---0.27

---0.24

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Nurix Therapeutics Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 NRIX 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Nurix Therapeutics Inc 財年末的營收是多少？



Nurix Therapeutics Inc 2025 財年營收為 83.98M，高於上一財年的 54.55M。

Nurix Therapeutics Inc 最近一個季度的營收是多少？



Nurix Therapeutics Inc 最近一個季度的營收為 9.04M，同比增長 -79.47%。

Nurix Therapeutics Inc 全年的淨利潤是多少？



Nurix Therapeutics Inc 2025 財年淨利潤為 -264.46M。

Nurix Therapeutics Inc 上一季度的淨利潤是多少？



Nurix Therapeutics Inc 最近一個季度的淨利潤為 -89.53M。

Nurix Therapeutics Inc 年度營業利潤是多少？



Nurix Therapeutics Inc 2025 財年的營業利潤為 -285.67M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。